Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
出版年份 2021 全文链接
标题
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma
作者
关键词
-
出版物
JAMA Surgery
Volume -, Issue -, Pages -
出版商
American Medical Association (AMA)
发表日期
2021-05-06
DOI
10.1001/jamasurg.2021.0954
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mRECIST for HCC: Performance and novel refinements
- (2020) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant
- (2020) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- Unknown
- (2018) LIVER TRANSPLANTATION
- Is it Time to Abandon the Milan Criteria?
- (2018) Karim J. Halazun et al. ANNALS OF SURGERY
- Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
- (2017) Andrea Notarpaolo et al. JOURNAL OF HEPATOLOGY
- Unknown
- (2017) LIVER TRANSPLANTATION
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
- (2015) Gary S. Collins et al. ANNALS OF INTERNAL MEDICINE
- Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
- (2015) Christian Toso et al. HEPATOLOGY
- A Novel Prognostic Nomogram Accurately Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Analysis of 865 Consecutive Liver Transplant Recipients
- (2015) Vatche G. Agopian et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Net Reclassification Improvement: Computation, Interpretation, and Controversies
- (2014) Maarten J.G. Leening et al. ANNALS OF INTERNAL MEDICINE
- Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series
- (2014) G. Sapisochin et al. ANNALS OF SURGICAL ONCOLOGY
- Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria
- (2014) Bilal Hameed et al. LIVER TRANSPLANTATION
- Net Reclassification Indices for Evaluating Risk Prediction Instruments
- (2013) Kathleen F. Kerr et al. EPIDEMIOLOGY
- Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: Implications for the current organ allocation policy
- (2013) Neil Mehta et al. LIVER TRANSPLANTATION
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor
- (2009) E. Vibert et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma
- (2009) Karim J. Halazun et al. ANNALS OF SURGERY
- Role of α-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?
- (2009) Stephen L Chan et al. Future Oncology
- RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma
- (2008) Yung-Ming Jeng et al. HEPATOLOGY
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started